RE:Nuvei short-seller“Nuvei commands a premium valuation to financial technology peers at 15x and 34x 2022E sales and EBITDA"
and here we are trading at ~3X F2022 Sales...
it's always interesting to me how so many US listed names trade at multiples light years beyond Canadian listings. I think US institutional investors are far more comfortable paying for future growth potential.